abstract |
The present invention is directed to N-(2-(cycloamine) ethyl) benzamide derivatives with chemical formula (I) as P2X7 inhibitors, pharmaceutical compositions comprising said compounds and these compounds for treating pain, inflammation, nerve disorders, or neuropsychiatric disorders. |